Auna Reports Preliminary Key Performance Indicators for the First Quarter ended March 31, 2026

LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna.

# (000)

8,053

8,170

7,274

8,002

# (000)

4,687

4,904

5,177

5,028

25,344

24,791

25,450

24,156

%

39.8%

38.5%

39.1%

37.1%

2,333

2,690

3,678

3,983

# (000)

37,866

47,602

49,049

47,885

# (000)

5,360

5,438

5,034

4,973

24,990

25,789

26,912

26,486

%

74.0%

73.6%

76.0%

74.8%

12,831

12,787

11,027

12,296

# (000)

1,364,710

1,388,579

1,395,509

1,424,695

# (000)

36,386

36,052

37,323

35,289

# (000)

10,653

10,484

11,209

10,443

78,254

78,583

80,176

79,349

%

76.9%

76.4%

77.1%

76.3%

-

-

-

3,036,335

36,884

33,912

36,668

35,941

1) Emergency care includes the number of visits to the emergency rooms and may include several visits per patient.

2) Number of surgeries includes inpatient surgeries, outpatient surgeries and cesarean sections.

3) Total number of days during which any of Auna's beds were occupied by a hospitalized patient during the period, including ICU.

4) Total capacity utilization is calculated as (i) (x) total number of days in which any of Auna's beds had a hospitalized patient during the period divided by (y) total number of beds, times (ii) total number of days during the period.

5) Intravenous chemotherapy and radiotherapy infusions in both inpatient and outpatient care; excludes oral treatments. In Peru, includes sessions across the Healthcare Services Network and OncoSalud Segments.

6) As of period end and as reported to the National Superintendence of Health Susalud in Peru.

7) Insured population assigned to Auna under risk-sharing agreements in Colombia. Tracking began in 4Q25.

Auna is one of Latin America’s leading healthcare platforms, with operations in Mexico, Peru, and Colombia. It prioritizes prevention and focuses on complex diseases that represent the highest healthcare spending. Its mission is to transform healthcare by delivering access to a highly integrated offering of services in low-penetration markets across Spanish-speaking Latin America. Founded in 1989, Auna has built one of the region’s largest modern healthcare platforms, consisting of a horizontally integrated network of medical care centers and a vertically integrated portfolio of oncology and general health plans. As of March 31, 2026, Auna’s network included 31 healthcare facilities—hospitals, ambulatory centers, and prevention and wellness centers—with a total of 2,333 beds and 1.4 million health plan members.

The information contained in this press release is preliminary in nature and is provided for informational purposes only. It is based on current estimates, assumptions, and expectations, which remain subject to ongoing review, verification, and possible revision. Final first quarter ended March 31, 2026 Key Performance Indicators may differ from those set forth herein. Readers are cautioned not to place undue reliance on these preliminary results.

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often are proceeded by words such as “believes,” “expects,” “may,” “anticipates,” “plans,” “intends,” “assumes,” “will” or similar expressions. The forward-looking statements contained herein include statements about our intention to publish these key performance indicators on a quarterly basis going forward. These expectations may or may not be realized. Some of these expectations may be based upon assumptions or judgments that prove to be incorrect. In addition, Auna’s business and operations involve numerous risks and uncertainties, many of which are beyond the control of Auna, which could result in Auna’s expectations not being realized or otherwise materially affect the financial condition, results of operations and cash flows of Auna. Some of the factors that could cause future results to materially differ from recent results or those projected in forward-looking statements are described in Auna’s filings with the United States Securities and Exchange Commission, including its annual report filed on Form 20-F on April 10, 2025.

The forward-looking statements are made only as of the date hereof, and Auna does not undertake any obligation to (and expressly disclaims any obligation to) update any forward-looking statements to reflect events or circumstances after the date such statements were made, or to reflect the occurrence of unanticipated events. In light of the risks and uncertainties described above, and the potential for variation of actual results from the assumptions on which certain of such forward-looking statements are based, investors should keep in mind that the results, events or developments disclosed in any forward-looking statement made in this document may not occur, and that actual results may vary materially from those described herein, including those described as anticipated, expected, targeted, projected or otherwise.